company background image
AKBM

Aker BioMarine OB:AKBM Stock Report

Last Price

kr44.85

Market Cap

kr3.9b

7D

-14.6%

1Y

-0.3%

Updated

29 Sep, 2022

Data

Company Financials +
AKBM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health2/6
Dividends0/6

AKBM Stock Overview

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

Aker BioMarine AS Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aker BioMarine
Historical stock prices
Current Share Pricekr44.85
52 Week Highkr59.90
52 Week Lowkr40.10
Beta1.14
1 Month Change-11.19%
3 Month Change-9.03%
1 Year Change-0.33%
3 Year Changen/a
5 Year Changen/a
Change since IPO-57.16%

Recent News & Updates

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Today we will run through one way of estimating the intrinsic value of Aker BioMarine AS ( OB:AKBM ) by taking the...

Shareholder Returns

AKBMNO FoodNO Market
7D-14.6%-24.0%-6.3%
1Y-0.3%-29.9%-7.0%

Return vs Industry: AKBM exceeded the Norwegian Food industry which returned -28.4% over the past year.

Return vs Market: AKBM exceeded the Norwegian Market which returned -4.5% over the past year.

Price Volatility

Is AKBM's price volatile compared to industry and market?
AKBM volatility
AKBM Average Weekly Movement5.3%
Food Industry Average Movement6.5%
Market Average Movement6.7%
10% most volatile stocks in NO Market11.2%
10% least volatile stocks in NO Market3.8%

Stable Share Price: AKBM is not significantly more volatile than the rest of Norwegian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: AKBM's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006429Matts Johansenhttps://www.akerbiomarine.com

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application.

Aker BioMarine AS Fundamentals Summary

How do Aker BioMarine's earnings and revenue compare to its market cap?
AKBM fundamental statistics
Market Capkr3.93b
Earnings (TTM)kr111.56m
Revenue (TTM)kr2.88b

35.2x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AKBM income statement (TTM)
RevenueUS$267.96m
Cost of RevenueUS$175.10m
Gross ProfitUS$92.86m
Other ExpensesUS$82.47m
EarningsUS$10.39m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 01, 2022

Earnings per share (EPS)0.12
Gross Margin34.65%
Net Profit Margin3.88%
Debt/Equity Ratio93.1%

How did AKBM perform over the long term?

See historical performance and comparison